Lv1
70 积分 2021-01-15 加入
Disitamab Vedotin: First Approval
2天前
已完结
Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2–positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Final overall survival (OS) results from a randomized, multicenter, open-label, phase 2 study (DESTINY-Gastric01)
2个月前
已关闭
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
2个月前
已完结
Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism
3个月前
已完结
Synthesis and in Vitro Antitumor Effect of Vinblastine Derivative−Oligoarginine Conjugates
3个月前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
5个月前
已完结
Subcutaneous amivantamab (ami) in patients (pts) with advanced solid malignancies: The PALOMA study—Updated safety and identification of the recommended phase 2 dose
5个月前
已完结
Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
6个月前
已完结
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
7个月前
已完结
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
7个月前
已完结
皖公网安备34019202002308
